Benefits, limitations and opportunities of NOTCH inhibitors for treatment of glioma

Sanaz Yahyanejad, Patrick V. Granton, Ann Hoeben, Marc A. Vooijs*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)S290-S295
JournalTranslational Cancer Research
Volume5
DOIs
Publication statusPublished - Aug 2016

Keywords

  • NOTCH
  • glioma
  • gamma-secretase inhibitors (GSI)
  • clinical
  • clinical trial
  • biomarker

Cite this